Intelligent Bio Solutions Inc. - Common Stock INBS 深 滬
已收盤 08-08 16:00:00 美东时间
1.52
-0.030
-1.94%
華盛通- 最 高1.58
- 今 開1.58
- 成交量 7.78万股
- 最 低 1.4841
- 昨 收 1.55
- 總市值 1327.63万
- 52周最高 3.00
- 市盈率 靜 --
- 換手率 0.89%
- 52周最低 1.02
- 委 比 37.73%
- 總股本 873.44万
- 歷史最高 3417.60
- 量 比 0.41
- 振 幅 6.19%
- 歷史最低 1.10
- 每 手 1
- 風險率 1.30%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Intelligent Bio Solutions Announces Preliminary Fiscal Fourth Quarter Revenue with Double-Digit Sequential and Year-Over-Year Growth and Strong Operational Momentum
Intelligent Bio Solutions Inc. expects a 16% sequential and year-over-year revenue growth in its fiscal fourth quarter ended June 30, 2025, driven by higher-margin cartridge sales and account growth. The company submitted an FDA 510(k) application for its opiate test system, upgraded its drug screening system for global adoption, and launched localized websites and CRM enhancements in Europe, the Middle East, and Latin America. Preliminary result...
08-07 12:30
Intelligent Bio Solutions Submits Key FDA Information
Intelligent Bio Solutions ( ($INBS) ) has shared an announcement. On August 6, ...
08-06 21:50
Intelligent Bio Solutions Strengthens FDA 510(k) Package with New Cybersecurity and Performance Data Ahead of Planned U.S. Market Launch
Intelligent Bio Solutions Inc. (INBS) submitted additional information to the FDA as part of its 510(k) clearance process for market entry later this year. The submission includes new data from cybersecurity and electromagnetic compatibility testing, totaling over 1900 pages and reinforcing the security and performance of its fingerprint sweat-based drug screening technology. INBS has also validated its technology's accuracy using advanced quanti...
08-06 12:30
Intelligent Bio Solutions Secures Major Drug Testing Tender with Leading London Transport Operator
Intelligent Bio Solutions Inc. (INBS) has secured a major contract with a leading public transport operator in London to deploy its Intelligent Fingerprinting Drug Screening System across 14 operational sites. The system, which provides rapid, non-invasive drug testing, aims to enhance workforce efficiency and safety. INBS, a medical technology company, has over 450 accounts in 24 countries and plans to expand further globally, including a focus ...
07-30 12:30
Intelligent Bio Solutions Inc. Enters Into Agreements to Raise $3.8 Million in Gross Proceeds
Intelligent Bio Solutions Inc. announces an agreement with certain warrant holders to exercise or prepay existing warrants to purchase up to 2,023,228 shares at $1.90 per share, generating approximately $3.8 million in gross proceeds. The Company plans to use the funds to complete its 510k filing with the U.S. FDA for its Fingerprint Drug Screening System and for general corporate purposes. Additionally, exercising holders will receive new warran...
07-25 12:30
EXCLUSIVE: Intelligent Bio Solutions' New Data Confirms Ability To Detect Trace Sweat Volumes At Ultra-Micro Level
Intelligent Bio strengthens its FDA 510(k) submission with new data, cybersecurity tests, and advanced fingerprint sweat analysis technology.
07-23 20:03
Intelligent Bio Solutions to Strengthen FDA 510(k) Submission with New Positive Data Demonstrating Ultra-Precise Fingerprint Sweat Detection and Platform Resilience
Intelligent Bio Solutions Inc. announced new data strengthening its FDA 510(k) submission for its fingerprint drug screening system. Tests confirmed the system's resilience, security, and ability to detect ultra-trace sweat volumes. The company plans to submit findings to the FDA in August, aiming for U.S. market entry in 2025. Supported by cybersecurity validations and precise sweat analysis, the technology addresses workplace safety needs acros...
07-23 12:30
Intelligent Bio Solutions Accelerates Global Growth with SmarTest® Patch Agreement, Reinforces U.S. Expansion Path as FDA Approval Remains a Strategic Priority
Intelligent Bio Solutions Inc. (INBS) has entered a global distribution agreement with SMARTOX to launch the SmarTest Patch for drug detection in international markets beyond the U.S. and Canada. This collaboration strengthens INBS's position as a leader in non-invasive drug testing solutions, particularly in the justice and rehabilitation sectors. The SmarTest Patch enables continuous sweat-based drug detection over extended periods, complementi...
07-16 12:30
Intelligent Bio Solutions Adds Next-Gen Wearable for Extended Drug Detection to Product Offering, Strengthening Leadership in Non-Invasive Testing
Intelligent Bio Solutions Inc. (INBS) has added the SmarTest® Patch, a wearable device developed by SMARTOX®, to its non-invasive drug testing solutions. The patch continuously detects drugs through sweat over 7 to 10 days, complementing INBS's fingerprint sweat analysis system and expanding its product portfolio. The device is discreet, water-resistant, and tamper-evident, detecting substances like cocaine, opiates, methamphetamines, marijuana, ...
07-15 12:30
Intelligent Bio Solutions Study Confirms Codeine Detection In Fingerprint Sweat, Validating Non-Invasive Drug Screening System
Data shows excretion of codeine in fingerprint sweatINBS' System is viable option for non-invasive diagnostic testingNEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS"
07-10 20:38
